secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Essence Corp (BIOE)
CIK:        0001723059
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001213900-23-095369
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bio Essence sells subsidiary BEP for $300K; director Sharon Mair resigns
------------------------------------------------------------------------

- Sold wholly owned subsidiary Bio Essence Pharmaceutical to Newways, Inc. for $300,000 cash; close expected by Dec 31, 2023.
- Board approved sale on Dec 5, 2023; Stock Purchase Agreement executed Dec 12, 2023.
- Director Sharon Mair resigned from Board effective Dec 8, 2023, with no material dispute reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723059/000121390023095369/0001213900-23-095369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723059/000121390023095369/ea189979-8k_bioessence.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-095369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer